Skip to main content

Russell Investments Group, Ltd.

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in ESPR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$0
+$0 QoQ
Shares Held
119,340
+455.5% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $362,370,004 across 49 Drug Manufacturers - Specialty & Generic names. ESPR ranks #49 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 119,340
2026-03-31 21,483
2025-12-31 21,573
2025-09-30 21,483
2025-06-30 4,451
2025-03-31 6,502
2024-12-31 489
2024-09-30 489
2024-03-31 84,367
2023-12-31 84,696
2023-09-30 86,334
2023-06-30 14,250
2023-03-31 21,539
2022-12-31 17,252
2021-09-30 94,505
2021-03-31 31,565
2020-12-31 44,064
2020-09-30 77,439
2020-06-30 51,028
2020-03-31 52,587